Skip to main content
LITS logo

LITS · Lite Strategy, Inc. · Financials

Track LITS — free
$1.38 +0.01 (+0.36%) At close · Oct 2
Market Cap
$49.00M
Shares
30.41M
Volume · Oct 2 1.01M Avg daily vol (3M) 430.21K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$0 -100%
FY2025 Revenue FY2017–FY2025
Net Income
-$71.15M -346.2%
FY2026 Net Income FY2007–FY2026
Gross Margin
100% +4pp
FY2022 Gross Margin FY2017–FY2022
Operating Margin
22.27% +97.6pp
FY2024 Operating Margin FY2017–FY2024
Diluted EPS
-$2.06 +13.8%
FY2026 Diluted EPS FY2015–FY2026
Operating Cash Flow
-$9.12M +56.2%
FY2026 Operating Cash Flow FY2011–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008 FY2007 FY2006 FY2005 FY2004 FY2003 FY2002
— $0 $65.3M $48.82M $40.7M $34.8M $27.76M $4.92M $1.62M $23.25M — — — — — — — — — — — — — — —
$267K $1.03M — — — — — — — — — — — — — — — — — — — — — — —
— — — — $0 $1.41M $2.67M $4.26M $3.38M $5M — — — — — — — — — — — — — — —
— — — — $40.7M $33.39M $25.09M $652K -$1.76M $18.25M — — — — — — — — — — — — — — —
— — — — 100% 95.95% 90.38% 13.27% -108.57% 78.49% — — — — — — — — — — — — — — —
$122K $3.92M $16.56M $52.45M $85.64M $69.4M $34.07M $32.3M $17.04M $7.24M $13.4M $23.82M $19.33M $6.08M $4.92M $2.12M — — — — — — — — —
$12.05M $13.53M $23.3M $33.13M $30.54M $24.41M $16.72M $14.6M $9.79M $8.63M $7.6M $8.95M $7.9M $5.14M $3.48M $4.34M — — — — — — — — —
— — — — — $0 $34M $35M $35K $35K $35K $34K $35K $30K $0 — — — — — — — — — —
$0 $368K $383K $386K $326K $285K $109K $80K $53K $85K $58K $64K $50K $45K $13K — — — — — — — — — —
— — — — — — — — — — $21M $32.77M $27.23M $11.22M $8.39M $6.45M — — — — — — — — —
$66.58M $17.46M $50.76M $85.58M $116.18M $95.22M $53.45M $51.16M $30.21M $20.87M $21M $32.77M — — — — — — — — — — — — —
-$66.58M -$17.46M $14.54M -$36.76M -$75.48M -$60.42M -$25.7M -$46.25M -$28.59M $2.38M -$21M -$32.77M -$27.23M -$11.22M -$8.39M -$6.45M — — — — — — — — —
— — 22.27% -75.31% -185.48% -173.65% -92.58% -940.9% -1762.39% 10.25% — — — — — — — — — — — — — — —
-$66.58M -$17.09M $14.93M -$36.38M -$75.16M -$60.14M -$25.59M -$46.17M -$28.53M $2.47M -$20.95M -$32.71M -$27.18M -$11.18M -$8.38M — — — — — — — — — —
-$4.57M $1.51M $3.24M $4.93M $21.03M $19.11M -$21.48M $0 — — — — — — $871K -$330K — — — — — — — — —
— — — — — — — — — — — — — — $100K — — — — — — — — — —
-$71.15M -$15.95M $17.78M -$31.84M -$54.45M -$41.31M -$47.17M -$16.82M -$40.07M $2.67M -$20.86M -$32.69M -$27.15M -$11.19M -$7.52M -$6.78M — — — — — — — — —
$0 $0 $0 $0 $0 $8000 $1000 $1000 $1000 $1000 $1000 $1000 $1000 $1000 $1000 $1000 — — — — — — — — —
-$71.15M -$15.95M $18M -$32M -$54M -$41M -$47.17M -$16.82M -$40.07M $2.67M -$20.86M -$32.69M -$27.15M -$11.19M -$7.52M -$6.78M -$7.9M -$11.18M -$12.41M -$13.82M -$7.39M -$6.42M -$8.54M -$3.03M -$123K
— — 27.57% -65.55% -132.69% -117.83% -169.96% -342.2% -2470.28% 11.48% — — — — — — — — — — — — — — —
— — — -$31.84M -$54.45M -$41.31M -$47.17M -$16.82M -$40.07M $2.67M — — — — — — — — — — — — — — —
— — — — — — — — — — — — — -$11.19M -$7.52M -$6.78M -$7.9M -$11.18M -$12.41M -$13.82M -$7.39M -$6.42M -$8.57M -$3M —
USD/shares -$2.06 -$2.39 $2.67 -$4.78 -$8.75 -$7.40 -$10.40 -$4.80 -$19.40 $1.40 -$12.20 -$23.20 — — — — — — — — — — — — —
USD/shares -$2.06 -$2.39 $2.67 -$4.78 -$9.99 -$12.00 -$10.40 -$15.00 -$19.40 $1.40 -$12.20 -$23.20 — — — — — — — — — — — — —
shares 34.56M 6.66M 6.66M 6.66M 6.22M 5.63M 4.55M 3.56M 2.07M 1.84M 1.72M 1.41M 1M 508.04K 112.39K 382.17K — — — — — — — — —
shares 34.56M 6.66M 6.66M 6.66M 6.26M 5.72M 4.55M 3.62M 2.07M 1.85M 1.72M 1.41M 1M 508.04K 112.39K 382.17K — — — — — — — — —
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: $4.9M in buybacks, $11.66M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2024-06-30 USD 0 10-K filed 2024-09-19
Noncurrent operating lease liabilities 2024-06-30 USD 0 10-K filed 2024-09-19
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 4.45×
EV/EBIT
—
P/E (TTM)
—
Peer median 3.98×

Peer medians compare against the 291 similar-size Biotechnology companies (of 532 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 1262104 CUSIP 55279B301 13F (30d) 1 filings 1 filers Visit website Investor relations